MF: C35H46FN5O9S MW: 731.83 An inhibitor of the NS3/4A protease of hepatitis C virus (HCV).
Protein-Interacting Inhibitors, Activators & Substrates
HCV Protease Inhibitors
Danoprevir (CAS 850876-88-9)
ITMN 191; RG 7227
Danoprevir is an inhibitor of the NS3/4A protease of hepatitis C virus (HCV)
C 35H 46FN 5O 9S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use. *
Certificate of Analysis for lot specific data (including water content).
Click on image or enlarge button to enlarge
Danoprevir is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with an IC
50 of 0.2-3.5 nM.
≥144 mg/mL in DMSO <1 mg/mL in Water ≥144 mg/mL in Ethanol
Store at -20° C
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.